Pioneer in living medicines
Redbiotec is a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. Founded in 2006 as a spin-off of the Swiss Federal Institute of Technology in Zurich (ETH Zurich), the company has won several awards, including the renowned W.A. De Vigier Award.
Redbiotec is backed by experienced institutional and private investors. Select key investors include Zürcher Kantonalbank (ZKB Group) – Switzerland’s largest cantonal bank with S&P AAA credit rating since 1994, and Redalpine Capital, a European seed and early-stage venture investor.